190 related articles for article (PubMed ID: 16844431)
1. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Johnson J; Holliman R; Baines DL; Philips BJ; Geddes DM; Hodson ME; Baker EH
J Cyst Fibros; 2007 Apr; 6(2):101-9. PubMed ID: 16844431
[TBL] [Abstract][Full Text] [Related]
2. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
4. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
7. Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth.
Garnett JP; Gray MA; Tarran R; Brodlie M; Ward C; Baker EH; Baines DL
PLoS One; 2013; 8(10):e76283. PubMed ID: 24124542
[TBL] [Abstract][Full Text] [Related]
8. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
9. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
[TBL] [Abstract][Full Text] [Related]
10. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
Costa M; Potvin S; Hammana I; Malet A; Berthiaume Y; Jeanneret A; Lavoie A; Lévesque R; Perrier J; Poisson D; Karelis AD; Chiasson JL; Rabasa-Lhoret R
J Cyst Fibros; 2007 Nov; 6(6):376-83. PubMed ID: 17409029
[TBL] [Abstract][Full Text] [Related]
11. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
[TBL] [Abstract][Full Text] [Related]
12. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
[TBL] [Abstract][Full Text] [Related]
13. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
14. Validation of insulin secretion indices in cystic fibrosis patients.
Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
[TBL] [Abstract][Full Text] [Related]
15. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
16. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
17. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.
Hameed S; Morton JR; Jaffé A; Field PI; Belessis Y; Yoong T; Katz T; Verge CF
Diabetes Care; 2010 Feb; 33(2):221-6. PubMed ID: 19910502
[TBL] [Abstract][Full Text] [Related]
18. Glucose ingestion in cystic fibrosis induces severe redox imbalance: A potential role in diabetes.
Hunt WR; Hansen JM; Stecenko AA
J Cyst Fibros; 2020 May; 19(3):476-482. PubMed ID: 32115389
[TBL] [Abstract][Full Text] [Related]
19. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
20. The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.
Colomba J; Boudreau V; Lehoux-Dubois C; Desjardins K; Coriati A; Tremblay F; Rabasa-Lhoret R
J Cyst Fibros; 2019 Jul; 18(4):551-556. PubMed ID: 30711385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
